The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial experience of TAS-102 chemotherapy in Australian patients with chemorefractory metastatic colorectal cancer.
 
Azim Jalali
No Relationships to Disclose
 
Hui-Li Wong
Stock and Other Ownership Interests - Oncosil (I)
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Rachel Wong
No Relationships to Disclose
 
Margaret Lee
Travel, Accommodations, Expenses - Roche
 
Lucy Gately
No Relationships to Disclose
 
Matthew Loft
No Relationships to Disclose
 
Jeremy David Shapiro
No Relationships to Disclose
 
Suzanne Kosmider
No Relationships to Disclose
 
Jeanne Tie
Honoraria - Amgen; FivepHusion; Merck Serono; SERVIER
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Serono
Travel, Accommodations, Expenses - Merck Serono
 
Sumitra Ananda
No Relationships to Disclose
 
Justin Yeung
No Relationships to Disclose
 
Ross Jennens
No Relationships to Disclose
 
Belinda Lee
Honoraria - Roche
Travel, Accommodations, Expenses - Ipsen; Roche
 
Joseph James McKendrick
No Relationships to Disclose
 
Lionel Lim
No Relationships to Disclose
 
Muhammad Adnan Khattak
No Relationships to Disclose
 
Peter Gibbs
Honoraria - Amgen; Merck; MSD Oncology; Roche; Sanofi/Aventis; SERVIER
Research Funding - Amgen (Inst); Merck Serono (Inst); Roche (Inst); Ventana Medical Systems (Inst)
Travel, Accommodations, Expenses - Servier